Annette Lauridsen

Title: Annette Lauridsen: Innovator in Therapeutic Compounds

Introduction

Annette Lauridsen is a notable inventor based in Søborg, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. Her innovative work focuses on enhancing the permeability of the blood-brain barrier, which is crucial for effective drug delivery.

Latest Patents

Annette holds a patent for "Benzimidazol-2-one derivatives and their use." This patent describes certain 1,5-disubstituted benzimidazol-2-one compounds that are useful as therapeutic agents. The compounds may be represented by a specific formula where R' can be hydrogen or alkyl, R'' can be halogen or trihalogenmethyl, and Hlg represents halogen. Notably, if Hlg is fluorine, then R'' cannot be chlorine. The patent also covers the use of these compounds, or their pharmaceutically acceptable addition salts, in applications that benefit from increasing blood-brain barrier permeability.

Career Highlights

Annette Lauridsen is currently associated with Poseidon Pharmaceuticals A/S, where she continues to advance her research and development efforts. Her work is pivotal in creating new therapeutic options that can significantly impact patient care.

Collaborations

Some of her coworkers include Lars Siim Madsen and Camilla Ærteberg Bæk, who contribute to the collaborative environment at Poseidon Pharmaceuticals A/S.

Conclusion

Annette Lauridsen's innovative work in the field of therapeutic compounds exemplifies her commitment to advancing medical science. Her contributions, particularly in enhancing drug delivery through the blood-brain barrier, are noteworthy and have the potential to improve treatment outcomes for various conditions.